Long-term persistence of symptoms of dyspnoea in COVID-19 patients.
作者信息
Nguyen Nhu Ngoc, Hoang Van Thuan, Dao Thi Loi, Meddeb Line, Lagier Jean-Christophe, Million Matthieu, Raoult Didier, Gautret Philippe
机构信息
Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France; IHU-Méditerranée Infection, Marseille, France.
Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France; IHU-Méditerranée Infection, Marseille, France; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.
出版信息
Int J Infect Dis. 2022 Feb;115:17-23. doi: 10.1016/j.ijid.2021.11.035. Epub 2021 Nov 27.
Abstract
摘要
相似文献
1
Long-term persistence of symptoms of dyspnoea in COVID-19 patients.新冠病毒感染患者呼吸困难症状的长期持续情况。
Int J Infect Dis. 2022 Feb;115:17-23. doi: 10.1016/j.ijid.2021.11.035. Epub 2021 Nov 27.
2
Level of Dyspnoea in Patients with COVID-19 in Poland.波兰 COVID-19 患者的呼吸困难程度。
Int J Environ Res Public Health. 2022 Sep 26;19(19):12203. doi: 10.3390/ijerph191912203.
3
Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in 'long COVID' patients with persistent dyspnoea.心肺运动试验诊断“长新冠”持续呼吸困难患者的呼吸功能障碍。
BMJ Open Respir Res. 2022 Mar;9(1). doi: 10.1136/bmjresp-2021-001126.
4
Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors.过度通气作为 SARS-CoV-2 幸存者持续性呼吸困难的机制之一。
Eur Respir J. 2021 Aug 26;58(2). doi: 10.1183/13993003.01578-2021. Print 2021 Aug.
5
Diaphragmatic paralysis in COVID-19: a rare cause of postacute sequelae of COVID-19 dyspnoea.新型冠状病毒肺炎中的膈肌瘫痪：新型冠状病毒肺炎后呼吸困难的一种罕见病因。
BMJ Case Rep. 2021 Nov 23;14(11):e246668. doi: 10.1136/bcr-2021-246668.
6
Significant burden of post-COVID exertional dyspnoea in a South-Italy region: knowledge of risk factors might prevent further critical overload on the healthcare system.意大利南部地区与新冠后劳力性呼吸困难相关的负担显著：了解危险因素可能有助于防止医疗系统承受进一步的严重压力过载。
Front Public Health. 2023 Dec 21;11:1273853. doi: 10.3389/fpubh.2023.1273853. eCollection 2023.
7
The effects of COVID-19 on respiratory muscle performance: making the case for respiratory muscle testing and training.COVID-19 对呼吸肌功能的影响：呼吁开展呼吸肌测试和训练。
Eur Respir Rev. 2022 Oct 5;31(166). doi: 10.1183/16000617.0006-2022. Print 2022 Dec 31.
8
Happy hypoxemia, or blunted ventilation?快乐低氧血症，还是迟钝的通气？
Respir Res. 2021 Jan 6;22(1):4. doi: 10.1186/s12931-020-01604-9.
9
Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea.新型冠状病毒肺炎幸存者持续性呼吸困难的肺功能和功能能力。
Respir Physiol Neurobiol. 2021 Jun;288:103644. doi: 10.1016/j.resp.2021.103644. Epub 2021 Feb 27.
10
Emerging trends in management of long COVID with a focus on pulmonary rehabilitation: A review.长新冠管理的新兴趋势，重点关注肺康复：综述。
Clin Respir J. 2024 May;18(5):e13777. doi: 10.1111/crj.13777.
引用本文的文献
1
The ongoing impact of policy documents on the pandemic based on the framework of the "4Rs" theory and policy tools: in China.基于“4R”理论框架和政策工具的政策文件对中国疫情的持续影响
BMC Public Health. 2025 May 24;25(1):1926. doi: 10.1186/s12889-025-22504-x.
2
Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence.新冠后状况的全球患病率：前瞻性证据的系统评价与荟萃分析
Health Promot Chronic Dis Prev Can. 2025 Mar;45(3):112-138. doi: 10.24095/hpcdp.45.3.02.
3
Proposal and Definition of an Intelligent Clinical Decision Support System Applied to the Prediction of Dyspnea after 12 Months of an Acute Episode of COVID-19.一种应用于预测新冠病毒病急性发作12个月后呼吸困难的智能临床决策支持系统的提议与定义
Biomedicines. 2024 Apr 12;12(4):854. doi: 10.3390/biomedicines12040854.
4
Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis.长新冠发病机制中的线粒体氧化应激和线粒体 ROS 风暴。
Front Immunol. 2023 Dec 22;14:1275001. doi: 10.3389/fimmu.2023.1275001. eCollection 2023.
5
Significant burden of post-COVID exertional dyspnoea in a South-Italy region: knowledge of risk factors might prevent further critical overload on the healthcare system.意大利南部地区与新冠后劳力性呼吸困难相关的负担显著：了解危险因素可能有助于防止医疗系统承受进一步的严重压力过载。
Front Public Health. 2023 Dec 21;11:1273853. doi: 10.3389/fpubh.2023.1273853. eCollection 2023.
6
Assessing the impact of COVID-19 at 1-year using the SF-12 questionnaire: Data from the Anticipate longitudinal cohort study.使用 SF-12 问卷评估 COVID-19 对 1 年的影响：来自 Anticipate 纵向队列研究的数据。
Int J Infect Dis. 2022 May;118:236-243. doi: 10.1016/j.ijid.2022.03.013. Epub 2022 Mar 14.
本文引用的文献
1
Long COVID, a comprehensive systematic scoping review.长新冠，一项全面的系统范围综述。
Infection. 2021 Dec;49(6):1163-1186. doi: 10.1007/s15010-021-01666-x. Epub 2021 Jul 28.
2
Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.新冠肺炎（COVID-19）后住院幸存者中潜在呼吸道症状的流行情况：系统评价和荟萃分析。
Chron Respir Dis. 2021 Jan-Dec;18:14799731211002240. doi: 10.1177/14799731211002240.
3
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.法国马赛接受羟氯喹/阿奇霉素和其他方案治疗的 3737 例 COVID-19 患者的结局：一项回顾性分析。
Travel Med Infect Dis. 2020 Jul-Aug;36:101791. doi: 10.1016/j.tmaid.2020.101791. Epub 2020 Jun 25.
4
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.新兴人类致病冠状病毒 SARS-CoV、MERS-CoV 和 2019-nCoV 的病理学和发病机制的重叠和离散方面。
J Med Virol. 2020 May;92(5):491-494. doi: 10.1002/jmv.25709. Epub 2020 Feb 21.
5
Sex differences in the intensity and qualitative dimensions of exertional dyspnea in physically active young adults.身体活跃的年轻成年人运动性呼吸困难强度和质量维度的性别差异。
J Appl Physiol (1985). 2015 Nov 1;119(9):998-1006. doi: 10.1152/japplphysiol.00520.2015. Epub 2015 Sep 3.
6
Altered respiratory physiology in obesity.肥胖时呼吸生理的改变。
Can Respir J. 2006 May-Jun;13(4):203-10. doi: 10.1155/2006/834786.
Zotero 插件